Transthoracic echocardiography showing a) right heart dilatation in the apical four-chamber view and b) the sinus venosus atrial septal defect in the subxiphoid.

Slides:

Advertisements

Similar presentations

SPM 200 Clinical Skills Lab 1

Advertisements

Living anatomy of Heart Dr. Ashraf Hussain Echocardiogram An echocardiogram is a test in which ultrasound is used to examine the heart. Displaying a.

Fig. 1. Sinus venosus ASD with PAPVR

Butterfly in the Heart: Infective Endocarditis after MitraClip Procedure Aslannif Roslan, MRCP, Suraya Hani Kamsani, MRCP, Ahmad Tantawi Jauhari Aktifanus,

Echocardiography view

Complete Atrioventricular Canal: Comparison of Modified Single-Patch Technique With Two-Patch Technique Carl L. Backer, MD, Robert D. Stewart, MD, Frédérique.

Klaus Langes, MD, Dietmar Koschyk, MD, Detlef G. Mathey, MD

a) Normal parasternal long-axis view.

Radiology assessment of pulmonary amyloidosis

a) Measurement of the peak tricuspid regurgitant velocity

A 45-year-old with pulmonary hypertension

Flowchart showing the requirement for starting, documenting and evaluating the effect on quality of life (QoL) of interdisciplinary best supportive care.

Nat. Rev. Cardiol. doi: /nrcardio

Axial computed tomography (CT) images a) at baseline and b) at a 12-month follow-up scan, in a patient with idiopathic pulmonary fibrosis (IPF). b) Note.

Algorithm for the diagnosis and treatment of hepatopulmonary syndrome (HPS). Algorithm for the diagnosis and treatment of hepatopulmonary syndrome (HPS).

Serial computed tomography (CT) imaging for monitoring disease progression in patients with idiopathic pulmonary fibrosis. Serial computed tomography (CT)

Electromagnetic navigation image: the icon representing the locatable guide (arrow) can be seen 3 mm away from the centre of a small pulmonary nodule in.

Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.

Risk assessment and treat-to-target approach for pulmonary arterial hypertension. Risk assessment and treat-to-target approach for pulmonary arterial hypertension.

A) Healthcare utilisation, b) short form (SF)-12 scores and c) work productivity and activity impairment in patients with asthma (▓) and diabetes (▪) in.

Reverse remodelling of left and right cavities under specific therapy in a patient with severe idiopathic pulmonary arterial hypertension. a) Before specific.

Prevalence of chronic bronchitis in relation to active smoking, stratified by age. □: nonsmokers; ▒: 1–10 cigarettes per day; ░: 11–20 cigarettes per day;

Diagnostic imaging of distal chronic thromboembolic pulmonary hypertension lesions. a) Ventilation/perfusion scintigraphy. b) Conventional pulmonary angiography.

Positron emission tomography scan in the axial plane performed in June 2007 showing intense and homogeneous increased uptake of 18-fluorodeoxyglucose within.

Abnormal atrial strain with speckle-tracking echocardiography predicts the arrhythmic substrate of atypical right atrial flutter Hiroshi Kawakami, MD,

Profile of Pseudomonas aeruginosa resistance by country and antibiotic

A summary of the pathogenesis, pathophysiology and clinical implications of the pulmonary vascular and cardiac abnormalities in interstitial lung disease.

A) Pressure tracings from the aorta (AO) and pulmonary artery (PA), demonstrating systemic levels of pulmonary arterial pressures. a) Pressure tracings.

Effect of intravenous furosemide in a pulmonary arterial hypertension patient admitted with overt right heart failure documented by echo-Doppler of the.

The projected numbers of tobacco-related deaths between 2000–2035 in millions for a) the world and b) medium- and low-income countries (top) and high-income.

Prevalence of different aetiologies of pulmonary hypertension (PH) in the paediatric population (results from national registries and paediatric cohorts).

a) The Spiration (Spiration, Inc. , Redmond, WA, USA) device

Proteinase activated receptor-1 expression in a) weak immunostaining in normal lung tissue, b) intense immunostaining in idiopathic pulmonary fibrosis,

Survival in patients with pulmonary arterial hypertension based on aetiology. •: congenital heart disease; ▪: collagen vascular disease; ▵: HIV-related;

A) Measurement of the right atrial a) area and b) long axis for calculation of right atrial volume. c) Measurement of the left ventricular eccentricity.

Model for the association between pathological features, physiological alterations and their association with pathological and clinical features. Model.

Exercise confers cardioprotection through improved vascular function.

Outline of the distal lung regions in haematoxylin and eosin-stained lung tissue [115, 116] showing the inner airway wall (green arrowheads), smooth muscle.

Oxygen uptake and carbon dioxide removal in the membrane lung

Prevalence of pulmonary arterial hypertension (PAH) in patients with congenital heart disease (CHD) according to defect. Prevalence of pulmonary arterial.

Homogenisation of the distribution of lung aeration as a result of moving from a) the supine to b) the prone position during acute respiratory distress.

Cardiac magnetic resonance imaging of the heart in a patient with pulmonary arterial hypertension. a) Short axis image. #: dilated right ventricle; ¶:

Impact of dose adjustment in case of adverse drug reaction (ADR; includes dose interruption and/or reduction). a) No dose adjustment and b) dose adjustment.

Definition of pulmonary hypertension (PH) associated with left heart disease. mPAP: mean pulmonary arterial pressure; PAWP: pulmonary artery wedge pressure;

Laplace's law: T = (P×r)/2h.

Overall forest plot from meta-analysis carried out in 11 studies a) assessing the relative risk of adverse events; and subgroup analysis performed on studies.

Representative pressure tracings of a) pulmonary arterial pressure and b) pulmonary arterial wedge pressure (PAWP). Representative pressure tracings of.

The “route to quit” model, which indicates the contribution of different ways of quitting to overall rates of smoking cessation. #: in most cases nicotine.

Distribution of systolic pulmonary artery pressure (Ppa) in relation to functional class (FC) for congenital heart disease patients with a) atrial septal.

Effect of omalizumab (n = 209) on a) clinically significant and b) severe exacerbation rates, compared with placebo (n = 210). #: adjustment due to a pre-study.

Survival rates in older (>65 years) compared with younger (18–65 years) patients with idiopathic pulmonary arterial hypertension. a) Expected ( )

Progression in the patient’s pulmonary function tests from 2010 to a) Forced vital capacity (FVC); b) total lung capacity (TLC); c) diffusing capacity.

A–c) Chest computed tomography excluding acute lung embolism and parenchymal lung disease and d–g) echocardiography performed during diagnostic work-up.

Risk ratio (RR) and number needed to treat (NNT) are time-dependent measures. a) When an intervention is associated with constant relative risk reduction.

Single photon emission computed tomography ventilation images of a female asthmatic at a, b) baseline and c, d) post-methacholine challenge, at approximately.

Autofluorescence bronchoscopy can discriminate normal from abnormal bronchial mucosa due to the difference in fluorescence emission: normal bronchial mucosa.

Single photon emission computed tomography ventilation images of a male asthmatic subject at a, b) baseline and c, d) post-methacholine challenge, at approximately.

Abdominal magnetic resonance imaging of a patient with tuberous sclerosis complex lymphangioleiomyomatosis and multiple small renal angiomyolipomas (arrows)

Hugh D. White et al. JIMG 2013;6:

Left upper lobe complete atelectasis 2 days after implantation of four endobronchial valves into the left upper lobe in a patient with emphysema. a) Chest.

24-h blood pressure profile after a, d) one night of intermittent hypoxia (IH) exposure, b, e) 13 nights IH exposure and c, f) 5 days after cessation of.

Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.

Trends of mortality rates in the USA between 1930 and 2000 in males according to cancer site. –––––: stomach; ·······: prostate; –– –– ––: colon and rectum;

A 53-year-old patient with fibrosing mediastinitis

Mean change from baseline in percentage predicted forced vital capacity (FVC) in the a) phase III CAPACITY [27] and b) ASCEND [14] studies. #: n=174; ¶:

Baseline New York Heart Association functional class (NYHA FC) predicts survival in patients with pulmonary hypertension using infused epoprostenol therapy.

Disagreement in measuring the solid portion of a part-solid nodule when using different reconstruction algorithms and window settings. Disagreement in.

Flow–volume loops of test breaths and preceding control breaths of a representative chronic obstructive pulmonary disease patient with different degrees.

Calcium and vitamin D metabolism.

A) Mucosa-associated lymphoid tissue lymphoma in a 45-year-old woman with primary Sjögren's syndrome. a) Mucosa-associated lymphoid tissue lymphoma in.

Presentation transcript:

Transthoracic echocardiography showing a) right heart dilatation in the apical four-chamber view and b) the sinus venosus atrial septal defect in the subxiphoid paediatric view (white arrow) measuring 1.9 cm at its maximal diameter. Transthoracic echocardiography showing a) right heart dilatation in the apical four-chamber view and b) the sinus venosus atrial septal defect in the subxiphoid paediatric view (white arrow) measuring 1.9 cm at its maximal diameter. M.A. Gatzoulis, and G. Giannakoulas Eur Respir Rev 2010;19:340-344 ©2010 by European Respiratory Society